Skip to main content

Table 1 Baseline clinical characteristics

From: Accuracy and clinical feasibility of 3D-myocardial thickness map measured by cardiac computed tomogram

  Overall
(N = 120)
Age, years 60.0 ± 10.9
Male, n (%) 82 (68.3)
AF duration, median (IQR) 24 (12–48.5)
Comorbidities, n (%)
 Heart failure 26 (21.7)
 Hypertension 62 (51.7)
 Diabetes mellitus 25 (20.8)
 Stroke 15 (12.5)
 Vascular disease 7 (5.8)
 CHA2DS2-VASc score 1.97 ± 1.6
AAD use prior to the ablation, n (%)
 Class Ic 54 (45.0)
 Class III 64 (53.3)
Echocardiographic parameters
 LA dimension, mm 44.09 ± 5.6
 LA volume index, ml/m2 42.00 ± 11.9
 LV ejection fraction, % 60.52 ± 7.3
 E/Em 10.06 ± 4.7
  1. AAD, antiarrhythmic drug; LA, left atrium; LV, left ventricle; E/Em, mitral inflow velocity/mitral annulus tissue velocity